Chemoinformaics analysis of 10-Deoxygeniposidic acid
| Molecular Weight | 358.343 | nRot | 4 |
| Heavy Atom Molecular Weight | 336.167 | nRig | 17 |
| Exact Molecular Weight | 358.126 | nRing | 3 |
| Solubility: LogS | -1.016 | nHRing | 2 |
| Solubility: LogP | -0.686 | No. of Aliphatic Rings | 3 |
| Acid Count | 1 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 47 | No. of Aliphatic Hetero Cycles | 2 |
| No. of Heavy Atom | 25 | No. of Aromatic Carbocycles | 0 |
| nHetero | 9 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 22 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 16 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 9 | No. of Arom Bond | 0 |
| nHA | 8 | APOL | 48.6074 |
| nHD | 5 | BPOL | 28.1466 |
| QED | 0.387 |
| Synth | 4.537 |
| Natural Product Likeliness | 2.835 |
| NR-PPAR-gamma | 0.005 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0 |
| Pgp-sub | 0.061 |
| HIA | 0.939 |
| CACO-2 | -5.988 |
| MDCK | 0.000181838 |
| BBB | 0.61 |
| PPB | 0.308447 |
| VDSS | 0.297 |
| FU | 0.583408 |
| CYP1A2-inh | 0.006 |
| CYP1A2-sub | 0.025 |
| CYP2c19-inh | 0.015 |
| CYP2c19-sub | 0.058 |
| CYP2c9-inh | 0.002 |
| CYP2c9-sub | 0.076 |
| CYP2d6-inh | 0.011 |
| CYP2d6-sub | 0.121 |
| CYP3a4-inh | 0.012 |
| CYP3a4-sub | 0.052 |
| CL | 1.693 |
| T12 | 0.592 |
| hERG | 0.013 |
| Ames | 0.046 |
| ROA | 0.505 |
| SkinSen | 0.036 |
| Carcinogencity | 0.958 |
| EI | 0.009 |
| Respiratory | 0.107 |
| NR-Aromatase | 0.003 |
| Antiviral | Yes |
| Prediction | 0.743757 |